
Guangdong Marubi Biotechnology Co., Ltd.
SSE:603983.SS
46.27 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 846.649 | 1,017.436 | 600.043 | 685.839 | 655.665 | 683.79 | 477.034 | 582.66 | 476.746 | 588.019 | 326.522 | 434.501 | 382.674 | 649.317 | 263.915 | 469.68 | 404.116 | 607.696 | 343.573 | 423.364 | 370.356 | 589.267 | 396.733 | 450.066 | 364.791 | 520.106 | 327.124 | 393.49 | 335.044 |
Cost of Revenue
| 202.741 | 285.691 | 152.909 | 176.335 | 167.95 | 206.177 | 131.453 | 167.188 | 149.325 | 181.037 | 114.614 | 124.237 | 127.402 | 216.291 | 112.743 | 168.172 | 145.831 | 219.49 | 112.707 | 129.823 | 127.727 | 185.116 | 131.021 | 134.732 | 122.588 | 163.28 | 108.257 | 114.499 | 112.926 |
Gross Profit
| 643.908 | 731.745 | 447.135 | 509.504 | 487.715 | 477.613 | 345.58 | 415.471 | 327.421 | 406.982 | 211.908 | 310.264 | 255.273 | 433.026 | 151.171 | 301.508 | 258.286 | 388.206 | 230.866 | 293.541 | 242.629 | 404.151 | 265.712 | 315.334 | 242.204 | 356.826 | 218.868 | 278.991 | 222.118 |
Gross Profit Ratio
| 0.761 | 0.719 | 0.745 | 0.743 | 0.744 | 0.698 | 0.724 | 0.713 | 0.687 | 0.692 | 0.649 | 0.714 | 0.667 | 0.667 | 0.573 | 0.642 | 0.639 | 0.639 | 0.672 | 0.693 | 0.655 | 0.686 | 0.67 | 0.701 | 0.664 | 0.686 | 0.669 | 0.709 | 0.663 |
Reseach & Development Expenses
| 15.927 | 19.108 | 18.591 | 19.592 | 16.255 | 18.06 | 15.231 | 15.64 | 13.357 | 15.621 | 12.662 | 11.45 | 13.193 | 12.141 | 13.741 | 12.893 | 11.714 | 14.927 | 11.459 | 13.805 | 9.963 | 16.991 | 9.85 | 9.287 | 8.741 | 8.905 | 7.992 | 8.628 | 8.297 |
General & Administrative Expenses
| 24.534 | -28.646 | 52.087 | -1.652 | 20.81 | -30.885 | 59.381 | -6.932 | 20.746 | -36.609 | 61.675 | -7.242 | 24.71 | -29.283 | 52.15 | -4.181 | 21.138 | -20.889 | 24.106 | -4.764 | 14.845 | -17.56 | 25.921 | -0.882 | 15.253 | -23.846 | 16.305 | 22.861 | 12.735 |
Selling & Marketing Expenses
| 441.717 | 447.267 | 405.289 | 384.842 | 332.646 | 403.108 | 281.903 | 310.886 | 202.708 | 311.477 | 174.266 | 216.934 | 143.48 | 257.8 | 168.169 | 197.556 | 117.77 | 188.355 | 134.962 | 153.552 | 87.23 | 174.761 | 127.593 | 163.223 | 74.873 | 165.101 | 150.479 | 140.51 | 78.5 |
SG&A
| 466.251 | 418.621 | 457.375 | 405.555 | 357.276 | 436.745 | 341.283 | 303.954 | 223.454 | 274.868 | 235.941 | 209.691 | 168.191 | 228.518 | 220.319 | 193.375 | 138.908 | 167.465 | 159.068 | 148.789 | 102.075 | 157.201 | 153.514 | 162.342 | 90.126 | 141.255 | 166.784 | 163.371 | 91.236 |
Other Expenses
| -4.254 | 195.218 | -86.322 | -3.35 | -2.243 | -5.007 | 0.071 | -0.025 | 3.717 | 59.377 | -33.939 | 39.994 | 3.93 | 0.343 | -5.476 | 15.836 | -0.069 | -0.179 | 0.133 | -0.002 | -5.111 | -0.019 | 1.926 | -0.382 | -0.153 | -0.014 | 1.112 | 0.991 | 0.039 |
Operating Expenses
| 477.924 | 632.947 | 389.644 | 428.497 | 375.774 | 459.812 | 326.186 | 356.357 | 240.529 | 349.866 | 214.665 | 261.135 | 185.314 | 306.663 | 213.474 | 218.54 | 155.055 | 234.984 | 165.033 | 155.698 | 112.041 | 223.05 | 163.377 | 165.995 | 103.533 | 165.018 | 178.715 | 174.113 | 104.221 |
Operating Income
| 165.984 | 98.798 | 57.491 | 81.007 | 111.942 | 17.801 | 27.541 | 67.003 | 96.639 | 59.461 | 10.142 | 58.483 | 79.252 | 140.059 | -52.166 | 95.19 | 115.908 | 158.671 | 87.978 | 176.705 | 149.171 | 185.367 | 119.044 | 165.669 | 142.569 | 206.092 | 44.601 | 116.878 | 116.6 |
Operating Income Ratio
| 0.196 | 0.097 | 0.096 | 0.118 | 0.171 | 0.026 | 0.058 | 0.115 | 0.203 | 0.101 | 0.031 | 0.135 | 0.207 | 0.216 | -0.198 | 0.203 | 0.287 | 0.261 | 0.256 | 0.417 | 0.403 | 0.315 | 0.3 | 0.368 | 0.391 | 0.396 | 0.136 | 0.297 | 0.348 |
Total Other Income Expenses Net
| 0.168 | -0.302 | 0.01 | 13.962 | 0.014 | -1.875 | 0.071 | -0.025 | -0.421 | -0.134 | -0.522 | -0.101 | 0.002 | 0.343 | -0.438 | 10.798 | -0.069 | -0.179 | 0.133 | -0.002 | -5.111 | -0.019 | 1.926 | -0.382 | -0.153 | -0.014 | 1.112 | 0.991 | 0.039 |
Income Before Tax
| 166.151 | 98.496 | 57.5 | 94.97 | 129.69 | 127.707 | 27.612 | 66.979 | 96.218 | 59.327 | 9.62 | 58.381 | 79.253 | 140.402 | -52.604 | 105.988 | 115.839 | 158.492 | 88.11 | 176.703 | 144.06 | 185.348 | 120.97 | 165.286 | 142.416 | 206.078 | 45.713 | 117.869 | 116.639 |
Income Before Tax Ratio
| 0.196 | 0.097 | 0.096 | 0.138 | 0.198 | 0.187 | 0.058 | 0.115 | 0.202 | 0.101 | 0.029 | 0.134 | 0.207 | 0.216 | -0.199 | 0.226 | 0.287 | 0.261 | 0.256 | 0.417 | 0.389 | 0.315 | 0.305 | 0.367 | 0.39 | 0.396 | 0.14 | 0.3 | 0.348 |
Income Tax Expense
| 30.954 | -4.079 | -5.26 | 28.566 | 19.066 | 23.205 | -15.552 | 14.501 | 17.343 | 6.981 | 8.216 | 8.856 | 15.097 | 35.953 | -3.676 | 19.185 | 16.971 | 33.02 | 18.315 | 27.419 | 25.215 | 29.555 | 18.651 | 30.543 | 22.452 | 27.243 | 7.349 | 18.984 | 20.681 |
Net Income
| 135.045 | 102.825 | 62.266 | 65.908 | 110.629 | 85.59 | 43.144 | 52.015 | 78.67 | 54.173 | 1.404 | 51.593 | 65.476 | 105.918 | -47.146 | 89.021 | 100.128 | 126.435 | 69.836 | 149.284 | 118.845 | 155.794 | 102.747 | 136.137 | 120.211 | 179.438 | 40.997 | 98.885 | 95.958 |
Net Income Ratio
| 0.16 | 0.101 | 0.104 | 0.096 | 0.169 | 0.125 | 0.09 | 0.089 | 0.165 | 0.092 | 0.004 | 0.119 | 0.171 | 0.163 | -0.179 | 0.19 | 0.248 | 0.208 | 0.203 | 0.353 | 0.321 | 0.264 | 0.259 | 0.302 | 0.33 | 0.345 | 0.125 | 0.251 | 0.286 |
EPS
| 0.34 | 0.256 | 0.16 | 0.16 | 0.28 | 0.21 | 0.11 | 0.13 | 0.2 | 0.14 | 0.004 | 0.13 | 0.16 | 0.26 | -0.12 | 0.22 | 0.25 | 0.31 | 0.17 | 0.38 | 0.3 | 0.39 | 0.26 | 0.37 | 0.33 | 0.96 | 0.22 | 0.28 | 0.27 |
EPS Diluted
| 0.34 | 0.256 | 0.16 | 0.16 | 0.28 | 0.21 | 0.11 | 0.13 | 0.2 | 0.14 | 0.003 | 0.13 | 0.16 | 0.26 | -0.12 | 0.22 | 0.25 | 0.31 | 0.17 | 0.38 | 0.3 | 0.39 | 0.26 | 0.37 | 0.33 | 0.96 | 0.22 | 0.28 | 0.27 |
EBITDA
| 167.018 | 104.134 | 68.119 | 101.701 | 131.21 | 134.611 | 29.968 | 75.871 | 104.634 | 68.635 | 19.554 | 69.433 | 89.545 | 150.833 | -52.858 | 113.056 | 123.111 | 164.403 | 88.587 | 182.23 | 130.588 | 191.566 | 102.335 | 169.031 | 148.673 | 207.963 | 40.153 | 116.611 | 119.873 |
EBITDA Ratio
| 0.197 | 0.102 | 0.114 | 0.148 | 0.2 | 0.197 | 0.063 | 0.13 | 0.219 | 0.117 | 0.06 | 0.16 | 0.234 | 0.232 | -0.2 | 0.241 | 0.305 | 0.271 | 0.258 | 0.43 | 0.353 | 0.325 | 0.258 | 0.376 | 0.408 | 0.4 | 0.123 | 0.296 | 0.358 |